Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1995 Jun 24;310(6995):1619–1620. doi: 10.1136/bmj.310.6995.1619

Hepatitis C and haemophilia.

C A Lee
PMCID: PMC2550005  PMID: 7795437

Full text

PDF
1619

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brettler D. B., Mannucci P. M., Gringeri A., Rasko J. E., Forsberg A. D., Rumi M. G., Garsia R. J., Rickard K. A., Colombo M. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood. 1992 Jul 15;80(2):540–543. [PubMed] [Google Scholar]
  2. Devereux H., Telfer P., Dusheiko G., Lee C. Hepatitis C genotypes in haemophilic patients treated with alpha-interferon. J Med Virol. 1995 Mar;45(3):284–287. doi: 10.1002/jmv.1890450308. [DOI] [PubMed] [Google Scholar]
  3. Eyster M. E., Alter H. J., Aledort L. M., Quan S., Hatzakis A., Goedert J. J. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 1991 Nov 15;115(10):764–768. doi: 10.7326/0003-4819-115-10-764. [DOI] [PubMed] [Google Scholar]
  4. Eyster M. E., Diamondstone L. S., Lien J. M., Ehmann W. C., Quan S., Goedert J. J. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1993 Jun;6(6):602–610. [PubMed] [Google Scholar]
  5. Eyster M. E., Fried M. W., Di Bisceglie A. M., Goedert J. J. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood. 1994 Aug 15;84(4):1020–1023. [PubMed] [Google Scholar]
  6. Fletcher M. L., Trowell J. M., Craske J., Pavier K., Rizza C. R. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1754–1757. doi: 10.1136/bmj.287.6407.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kasper C. K., Kipnis S. A. Hepatitis and clotting-factor concentrates. JAMA. 1972 Jul 31;221(5):510–510. [PubMed] [Google Scholar]
  8. Kernoff P. B., Lee C. A., Karayiannis P., Thomas H. C. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol. 1985 Jul;60(3):469–479. doi: 10.1111/j.1365-2141.1985.tb07444.x. [DOI] [PubMed] [Google Scholar]
  9. Preston F. E., Jarvis L. M., Makris M., Philp L., Underwood J. C., Ludlam C. A., Simmonds P. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood. 1995 Mar 1;85(5):1259–1262. [PubMed] [Google Scholar]
  10. Telfer P., Sabin C., Devereux H., Scott F., Dusheiko G., Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol. 1994 Jul;87(3):555–561. doi: 10.1111/j.1365-2141.1994.tb08312.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES